CD109
CD109 antigen
Also known as: CD109_HUMAN, CPAMD7, DKFZp762L1111, FLJ38569
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6YHK3
- Gene
- CD109
- Ensembl
- ENSG00000156535
- Chromosome
- 6
- Canonical length
- 1445 aa
- Protein class
- CD markers, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a glycosyl phosphatidylinositol (GPI)-linked glycoprotein that localizes to the surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signalling by transforming growth factor beta (TGF-beta). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
1445 residues, UniProt reviewed canonical sequence.
>Q6YHK3|CD109
1 MQGPPLLTAA HLLCVCTAAL AVAPGPRFLV TAPGIIRPGG NVTIGVELLE HCPSQVTVKA
61 ELLKTASNLT VSVLEAEGVF EKGSFKTLTL PSLPLNSADE IYELRVTGRT QDEILFSNST
121 RLSFETKRIS VFIQTDKALY KPKQEVKFRI VTLFSDFKPY KTSLNILIKD PKSNLIQQWL
181 SQQSDLGVIS KTFQLSSHPI LGDWSIQVQV NDQTYYQSFQ VSEYVLPKFE VTLQTPLYCS
241 MNSKHLNGTI TAKYTYGKPV KGDVTLTFLP LSFWGKKKNI TKTFKINGSA NFSFNDEEMK
301 NVMDSSNGLS EYLDLSSPGP VEILTTVTES VTGISRNVST NVFFKQHDYI IEFFDYTTVL
361 KPSLNFTATV KVTRADGNQL TLEERRNNVV ITVTQRNYTE YWSGSNSGNQ KMEAVQKINY
421 TVPQSGTFKI EFPILEDSSE LQLKAYFLGS KSSMAVHSLF KSPSKTYIQL KTRDENIKVG
481 SPFELVVSGN KRLKELSYMV VSRGQLVAVG KQNSTMFSLT PENSWTPKAC VIVYYIEDDG
541 EIISDVLKIP VQLVFKNKIK LYWSKVKAEP SEKVSLRISV TQPDSIVGIV AVDKSVNLMN
601 ASNDITMENV VHELELYNTG YYLGMFMNSF AVFQECGLWV LTDANLTKDY IDGVYDNAEY
661 AERFMEENEG HIVDIHDFSL GSSPHVRKHF PETWIWLDTN MGYRIYQEFE VTVPDSITSW
721 VATGFVISED LGLGLTTTPV ELQAFQPFFI FLNLPYSVIR GEEFALEITI FNYLKDATEV
781 KVIIEKSDKF DILMTSNEIN ATGHQQTLLV PSEDGATVLF PIRPTHLGEI PITVTALSPT
841 ASDAVTQMIL VKAEGIEKSY SQSILLDLTD NRLQSTLKTL SFSFPPNTVT GSERVQITAI
901 GDVLGPSING LASLIRMPYG CGEQNMINFA PNIYILDYLT KKKQLTDNLK EKALSFMRQG
961 YQRELLYQRE DGSFSAFGNY DPSGSTWLSA FVLRCFLEAD PYIDIDQNVL HRTYTWLKGH
1021 QKSNGEFWDP GRVIHSELQG GNKSPVTLTA YIVTSLLGYR KYQPNIDVQE SIHFLESEFS
1081 RGISDNYTLA LITYALSSVG SPKAKEALNM LTWRAEQEGG MQFWVSSESK LSDSWQPRSL
1141 DIEVAAYALL SHFLQFQTSE GIPIMRWLSR QRNSLGGFAS TQDTTVALKA LSEFAALMNT
1201 ERTNIQVTVT GPSSPSPVKF LIDTHNRLLL QTAELAVVQP TAVNISANGF GFAICQLNVV
1261 YNVKASGSSR RRRSIQNQEA FDLDVAVKEN KDDLNHVDLN VCTSFSGPGR SGMALMEVNL
1321 LSGFMVPSEA ISLSETVKKV EYDHGKLNLY LDSVNETQFC VNIPAVRNFK VSNTQDASVS
1381 IVDYYEPRRQ AVRSYNSEVK LSSCDLCSDV QGCRPCEDGA SGSHHHSSVI FIFCFKLLYF
1441 MELWLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD109 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 311 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 311 nTPM
- skin: 18 nTPM
- smooth muscle: 12 nTPM
- endometrium: 12 nTPM
- esophagus: 9.7 nTPM
- cervix: 9.3 nTPM
Single-cell type
- hematopoietic stem cells: 391 nCPM
- megakaryocyte-erythroid progenitors: 201 nCPM
- ocular epithelial cells: 192 nCPM
- hofbauer cells: 172 nCPM
- thymic myoid cells: 140 nCPM
- thymocytes: 140 nCPM
Immune cell
- myeloid DC: 0.3 nTPM
- neutrophil: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- hypothalamus: 8.8 nTPM
- midbrain: 8.1 nTPM
- spinal cord: 8.1 nTPM
- medulla oblongata: 7.6 nTPM
- white matter: 6.6 nTPM
- thalamus: 5.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CD109.
Disease | ImmuneIEDB
Conditions an epitope on CD109 was assayed in.
- viral infectious disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.5
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- hair follicle development
- keratinocyte proliferation
- negative regulation of keratinocyte proliferation
- negative regulation of stem cell proliferation
- negative regulation of transforming growth factor beta receptor signaling pathway
- negative regulation of wound healing
- osteoclast fusion
- regulation of keratinocyte differentiation
- stem cell proliferation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Alpha-2-macroglobulin
- Macroglobulin domain
- Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid
- Alpha-macroglobulin, receptor-binding
- Alpha-2-macroglobulin, bait region domain
- Alpha-macroglobulin-like, TED domain
- Immunoglobulin-like fold
- Immunoglobulin E-set
- Alpha-2-macroglobulin, conserved site
- Alpha-macroglobulin, receptor-binding domain superfamily
- Macroglobulin domain MG3
- Alpha-2-macroglobulin, TED domain
- Alpha-macroglobulin-like, thiol-ester bond-forming region
- Alpha-2-macroglobulin/Complement system
- Alpha-2-macroglobulin family
- MG2 domain
- A-macroglobulin receptor binding domain
- A-macroglobulin TED domain
- Alpha-2-macroglobulin bait region domain
- Macroglobulin domain MG3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD109 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD109 as an antibody target. Whether an autoantibody or antibody against CD109 could matter depends on whether native CD109 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD109 is annotated at the cell surface, where native CD109 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD109 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...